MoneyWorks4Me

Sunil Healthcare - Quaterly Results

11 Aug 2023 Evaluate
The sales moved down -35.06% to Rs. 221.32 millions for the June 2023 quarter as compared to Rs. 340.81 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -7.56 millions as compared to Net Profit of Rs. 44.67 millions of corresponding quarter ended June 2022Operating profit for the quarter ended June 2023 decreased to 18.88 millions as compared to 85.48 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 221.32 340.81 -35.06 221.32 340.81 -35.06 1118.30 1163.73 -3.90
Other Income 8.16 3.35 143.58 8.16 3.35 143.58 16.29 15.54 4.83
PBIDT 18.88 85.48 -77.91 18.88 85.48 -77.91 209.37 193.66 8.11
Interest 12.66 8.19 54.58 12.66 8.19 54.58 41.68 34.89 19.46
PBDT 6.22 77.29 -91.95 6.22 77.29 -91.95 167.69 158.77 5.62
Depreciation 16.08 16.30 -1.35 16.08 16.30 -1.35 70.10 63.06 11.16
PBT -9.86 60.99 -116.17 -9.86 60.99 -116.17 97.59 95.71 1.96
TAX -2.30 16.32 -114.09 -2.30 16.32 -114.09 27.82 27.95 -0.47
Deferred Tax -2.30 6.14 -137.46 -2.30 6.14 -137.46 11.07 12.80 -13.52
PAT -7.56 44.67 -116.92 -7.56 44.67 -116.92 69.77 67.76 2.97
Equity 102.55 102.55 0.00 102.55 102.55 0.00 102.55 102.55 0.00
PBIDTM(%) 8.53 25.08 -65.99 8.53 25.08 -65.99 18.72 16.64 12.50
Peers
Company Name CMP
Godrej Industries 1087.70
SRF 2493.00
BASF India 3512.00
Pidilite Inds. 1490.15
Tata Chemicals 654.80
View more..